Clinical trials
Phase 3 Non-alcoholic Fatty Liver Disease trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 3 |
| 2008 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 4 |
| 2019 | 3 |
| 2021 | 4 |
| 2023 | 1 |
| 2024 | 5 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Recruiting | 8 |
| Active, not recruiting | 6 |
| Terminated | 6 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 5 |
| Madrigal Pharmaceuticals, Inc. | 3 |
| 89bio, Inc. | 2 |
| Akero Therapeutics, Inc | 2 |
| Gilead Sciences | 2 |
| Intercept Pharmaceuticals | 2 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2 |
| Boehringer Ingelheim | 1 |
| Eli Lilly and Company | 1 |
| Galmed Research and Development, Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-alcoholic Fatty Liver Disease | 30 |
| Fatty Liver | 10 |
| Fibrosis | 10 |
| Liver Diseases | 5 |
| Obesity | 3 |
| Digestive System Diseases | 2 |
| Dyslipidemias | 2 |
| Hyperlipidemias | 2 |
| Metabolic Diseases | 2 |
| Thyroid Hormone Resistance Syndrome | 2 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.